Raffone F
Dipartimento di Salute Mentale e Fisica e Medicina Preventiva, Università degli Studi della Campania "Luigi Vanvitelli", Naples, Italy.
PreprintKetamine
Intranasal Esketamine for Treatment-Resistant Depression: A Practical Clinical Guide to Patient Selection, Dosing, Combination Strategies and Adverse-Event Management
ArticlePsilocybin
Psilocybin and ayahuasca in treatment-resistant depression: clinical evidence, methodological constraints and ethical challenges: a narrative review.
ArticleKetamine
Reduction of Suicidality and Depressive Symptoms with Esketamine: Focus on Gender Differences
ArticleKetamine
Esketamine-based treatment, depression-specific metacognitive training, and their combination in treatment-resistant depression: 6-month trajectories of depressive symptoms and rumination in a multicenter observational study.
ArticleKetamine
Suicidal ideation covaries with depressive severity during six-month real-world esketamine treatment in a cohort enriched for borderline personality disorder.
ArticleKetamine
Intranasal esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A multicenter real-world longitudinal study.
ArticleKetamine
Toward Integrating Intranasal Esketamine with Traumatic-Memory Psychotherapy in Treatment-Resistant Depression: A Narrative Review and Feasibility-Oriented Protocol Proposal.
ArticleKetamine
Esketamine in treatment-resistant depression with and without comorbid borderline personality disorder: A real-world longitudinal study of suicidal ideation and self-harm.
ArticleKetamine
Integrating Psychiatric, Psychotherapeutic, and Nursing Care in Intranasal Esketamine for Treatment-Resistant Depression.
ArticleKetamine
Narrative Experiences of Esketamine-Induced Dissociation in Patients with Treatment-Resistant Depression: A Qualitative Exploratory Study.
ArticleKetamine
Personalizing esketamine treatment in TRD and TRBD: the role of mentalization, cognitive rigidity, psychache, and suicidality.
ArticleKetamine
Gender Differences in Suicidal and Self-Harming Responses to Esketamine: A Real-World Retrospective Study.
ArticleKetamine
Esketamine-induced dissociation: just a side effects or a potential antidepressant effect booster?
ArticleKetamine
Metacogntive training add-on to esketamine treatment in TRD patients: effects on depressive rumination
ArticleKetamine
Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.
ArticleKetamine